HCS-pharma
  • Home
  • About Us
    • Company
    • Team
    • Join us
    • News
    • Partners
    • Press
      • HCS Pharma in press
      • Press releases
      • Photos for the press
    • Legals
  • Services
    • Why HCS ?
    • Pharmacology
      • Neurodegenerative diseases
        • Parkinson
        • Alzheimer
      • Oncology
        • Cell cycle arrest
        • Cytotoxicity in 2D & 3D culture
        • Migration assay
      • Pharma custom assays
    • Toxicology
      • Genotoxicity
      • Hepatotoxicity
      • Neurotoxicity
    • Dermocosmetology
      • Aging
      • DNA damage protection assay
      • Moisturizing
      • Wound healing
      • Cosmetics custom assays
  • Posters
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter
    • Show previous newsletters
29Aug

alzheimer_Treatment of SH-SY5Y neuronal cells by Aftin 5 during 72H_2

Posted by: Grégory MAUBON
No comments

« alzheimer_Treatment of SH-SY5Y neuronal cells by Aftin 5 during 72H_2

Leave a Reply Cancel reply

Stay Connected

Linkedin Google Plus Twitter Facebook  youtube

Subscribe to our Newsletter

Your Needs

Dermocosmetology

Toxicology

Pharmacology

Contacts

HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS
See on map

HCS Pharma – Site de Rennes
Biopole
6 Rue Pierre Joseph Colin
35000 RENNES
See on map

Contact Us !
+33 769 999 137

Recent Posts

  • Validation of our new automation platform
  • Quantitative mRNA imaging in a small yet entire brain
  • Imaging 3D spheroïds with light sheet microscopy
  • La Donnée : l’ADN des sciences de la vie
  • Step by step, our laboratory in Lille becomes operational !

RSS Article en français

  • La Donnée : l’ADN des sciences de la vie
  • Sweetch Energy lève 1,4 million d’euros pour produire de l’électricité à partir d’eau salée
  • B°Ker sécurise le fonctionnement des laboratoires
  • Du Deep Learning pour aider au dépistage du cancer du poumon
  • Le site du projet CHOPIN est en ligne

Lauréat Réseau Entreprendre

ELRIGfr in Rennes, may 3&4

Search

CIR 2015/2017

CIR HCS Pharma est accrédité CIR pour la période 2015 à 2017

We talk about …

3D 3D culture analysis biopole cancer cell congress culture data dermocosmetology digital discovery dna drug ELRIG ELRIGfr genotoxicity HCA HCS hepg2 High content screening human imaging in vivo IPS laboratory Lille Live Cell Imaging meeting microscopy model oncology Parkinson Perkin Elmer phenotypic screening picture prize rennes screening startup toxicology UK video wound healing zebrafish

Choose where to go !

  • Home
  • About Us
    • Company
    • Team
    • Join us
    • News
    • Partners
    • Press
      • HCS Pharma in press
      • Press releases
      • Photos for the press
    • Legals
  • Services
    • Why HCS ?
    • Pharmacology
      • Neurodegenerative diseases
        • Parkinson
        • Alzheimer
      • Oncology
        • Cell cycle arrest
        • Cytotoxicity in 2D & 3D culture
        • Migration assay
      • Pharma custom assays
    • Toxicology
      • Genotoxicity
      • Hepatotoxicity
      • Neurotoxicity
    • Dermocosmetology
      • Aging
      • DNA damage protection assay
      • Moisturizing
      • Wound healing
      • Cosmetics custom assays
  • Posters
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter
    • Show previous newsletters

Recent Posts

  • Validation of our new automation platform
  • Quantitative mRNA imaging in a small yet entire brain
  • Imaging 3D spheroïds with light sheet microscopy
  • La Donnée : l’ADN des sciences de la vie
  • Step by step, our laboratory in Lille becomes operational !

Contacts

HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS

HCS Pharma – Site de Rennes
Biopole
6 Rue Pierre Joseph Colin
35000 RENNES

Contact Us !
+33 769 999 137

Newsletter subcription

* = required field

Categories

  • Brittany Biotechnology (12)
  • english (201)
  • francais (7)
  • Hauts de France Biotechnology (1)
  • HCS, HCA & Biology (106)
  • Join Us (3)
  • Langue (181)
  • Meeting (37)
  • Our news (63)
  • Posters & Publications (14)
(c) HCS Pharma 2017 - Legals - Contact - SIRET 80397658800027
HCS Pharma is a biotechnological startup focused on in vitro preclinical research development with a specialisation in cellular imagery : High Content Analysis (HCA) and High Content Screening (HCS)
Theme by Imon Themes
  • twitter
  • Google Plus
  • linked
  • rss